(Q39406137)

11 September 2017

title

Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells (English)

1 reference

11 September 2017

1 reference

Guo-Sheng Wu

1

1 reference

11 September 2017

Jin-Jian Lu

2

1 reference

11 September 2017

Jia-Jie Guo

3

1 reference

11 September 2017

Ming-Qing Huang

4

1 reference

11 September 2017

Li Gan

5

1 reference

11 September 2017

Xiu-Ping Chen

6

1 reference

11 September 2017

Yi-Tao Wang

7

1 reference

11 September 2017

publication date

1 January 2013

1 reference

11 September 2017

published in

Pharmacological Reports

1 reference

11 September 2017

volume

65

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

453-459

1 reference

Antimalarial dihydroartemisinin also inhibits angiogenesis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Generalized Equations for the Analysis of Inhibitions of Michaelis-Menten and Higher-Order Kinetic Systems with Two or More Mutually Exclusive and Nonexclusive Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Molecular modes of action of artesunate in tumor cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Experimental Therapy of Hepatoma with Artemisinin and Its Derivatives: In vitro and In vivo Activity, Chemosensitization, and Mechanisms of Action

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and NF-kappaB/AP-1-dependent mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Anti-cancer natural products isolated from chinese medicinal herbs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Qinghaosu (Artemisinin): The Price of Success

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2813%2971021-1

7 January 2021

10.1016/S1734-1140(13)71021-1

Identifiers

DOI

1 reference

11 September 2017

1 reference